CDSCO Flags Painkillers and Antibiotics Over Chronic Renal Failure and AMR Risks

India’s national drug regulator, the Central Drugs Standard Control Organisation (CDSCO) under the Directorate General of Health Services (DGHS), New Delhi, has issued a comprehensive nationwide safety advisory warning against the rampant, unguided consumption of non-steroidal anti-inflammatory drugs (NSAIDs) and broad-spectrum antibiotics.Governed strictly under the statutory framework of the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, the circular addresses healthcare practitioners, pharmacists, chemists, healthcare networks, and the general public, explicitly highlighting that repetitive, prolonged, or unmonitored use of everyday painkillers severely escalates the threat of irreversible chronic kidney disease (CKD), acute renal impairment, adverse drug reactions, and runaway antimicrobial resistance (AMR).Renal Hazards and Viral Inefficacy: Why Self-Medication Triggers Organ DamageThe drug regulatory authority explicitly directed that NSAIDs and antibiotics must never be taken indiscriminately or across extended durations without the direct diagnostic assessment and supervision of a Registered Medical Practitioner.Patients suffering from pre-existing renal deficiencies, diabetes, hypertension, or underlying renal impairment risk factors must seek immediate clinical consultation before touching pain-relief medications. Addressing self-medication trends, the CDSCO strongly condemned using antibiotics for uncomplicated viral infections such as seasonal colds and flu, where they offer zero clinical efficacy while wiping out beneficial microflora. Clinicians have been directed to strictly adhere to antimicrobial stewardship principles—basing prescriptions on suspected pathogen identification, infection severity, and local microbiological susceptibility profiles while avoiding improper dosing, prolonged courses, and unproven combination drug therapies.Strict Mandate for Pharmacists: Enforcing Schedule H Rules and Hospital MonitoringTo arrest the casual over-the-counter dispensing culture, the CDSCO circular commands retail pharmacists, distributors, and chemists to enforce statutory compliance regarding Schedule H and Schedule H1 prescription medications.Pharmacists are explicitly prohibited from selling prescription-only NSAIDs or antibiotics without a valid prescription from a registered doctor, and they must strictly cease facilitating or encouraging self-medication practices over the counter. Concurrently, hospitals and healthcare institutions have been instructed to establish institutional prescription audit committees, strengthen rational drug monitoring protocols, and provide structured patient counseling.State and Union Territory Drugs Control Authorities have been mobilized to conduct regional enforcement drives and verify retail compliance under the Drugs and Cosmetics Rules to avert a looming public health crisis driven by drug-induced nephropathy and antibiotic resistance.